ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,207Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 229

$262K Total Retail Price of All Prescriptions

Rank: 102 out of 229

101 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 101 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

24% of this provider’s 101 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 6,778 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

71 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LACTULOSE 496 453 1 66
OMEPRAZOLE 375 366 2 4
SIMVASTATIN 315 293 3 3
LEVOTHYROXINE SODIUM 283 271 4 1
CITALOPRAM HBR 273 261 5 21
LISINOPRIL 270 246 6 2
HYDROCODONE-ACETAMINOPHEN 225 214 S3 7 7
TAMSULOSIN HCL 209 208 8 24
FUROSEMIDE 193 181 9 8
NYSTATIN-TRIAMCINOLONE 192 171 10 188
POTASSIUM CHLORIDE 179 167 11 18
TRAZODONE HCL 155 155 12 34
MIRTAZAPINE 135 135 13 52
GABAPENTIN 123 123 14 10
SERTRALINE HCL 115 112 15 22
FINASTERIDE 108 96 16 55
CLOTRIMAZOLE 87 75 17 243
MUPIROCIN 85 85 18 244
ALBUTEROL SULFATE 82 82 19 201
METOPROLOL SUCCINATE 80 63 20 16
QUETIAPINE FUMARATE 78 78 21 90
IPRATROPIUM-ALBUTEROL 76 75 22 180
METFORMIN HCL 76 64 22 6
MORPHINE SULFATE ER 74 51 S2 24 70
AMLODIPINE BESYLATE 71 71 25 5
RANITIDINE HCL 67 67 26 32
NAMENDA 65 65 27 39
TRAMADOL HCL 62 62 28 26
CARVEDILOL 60 60 29 31
JANTOVEN 60 51 29 267
HYDROCHLOROTHIAZIDE 59 59 31 9
LANTUS 54 54 32 40
GEMFIBROZIL 53 53 33 62
LAMOTRIGINE 52 47 34 123
CHLORHEXIDINE GLUCONATE 50 43 35 308
SEROQUEL 50 50 35 308
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.